SRT3 Sartorius Aktiengesellschaft

XETRA · DE · Healthcare · Medical Instruments & Supplies · sartorius.com

251.60EUR+0.08%Mkt Cap: 18.88B $P/E: 88.901d ago

Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometr…

Industry Peers

Medical Instruments & Supplies

Screen all

ISRG

Intuitive Surgical, Inc.

$143.60BUSDP/E 46.6

EssilorLuxottica Société anonyme

$72.05BUSDP/E 27.0

BDX

Becton, Dickinson and Company

West Pharmaceutical Services, Inc.

$26.51BUSDP/E 48.2

DIM

Sartorius Stedim Biotech S.A.

Sartorius Aktiengesellschaft

$15.16BUSDP/E 71.4

SOLV

Solventum Corporation

$14.98BUSDP/E 10.8

BAX

Baxter International Inc.

$12.52BUSD

COO

The Cooper Companies, Inc.

The Cooper Companies, Inc.

$10.29BUSDP/E 18.6

ALGN

Align Technology, Inc.

Bausch + Lomb Corporation

$6.13BUSD

Key Statistics

Company

Market Cap18.88B USD

Enterprise Value24.23B USD

Revenue (TTM)3.89B USD

Gross Profit1.78B USD

Net Income (TTM)168.37M USD

Revenue/Share51.24 EUR

Last Price251.60 EUR

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees14.3K

CountryDE

SectorHealthcare

IndustryMedical Instruments & Supplies

ISINDE0007165631

Valuation

P/E (Trailing)88.90

P/E (Forward)39.71

PEG0.94

EV/EBITDA23.76

EV/Revenue6.22

P/S4.85

P/B6.41

EPS (TTM)2.83

EPS (Forward)6.33

52W Range

198.5074% of range270.00

52W High270.00 EUR

52W Low198.50 EUR

Profitability

Gross Margin46.26%

Oper. Margin18.00%

EBITDA Margin26.20%

Profit Margin4.38%

ROE5.72%

ROA1.59%

Growth

Revenue Growth3.10%

Earnings Growth—

Cash Flow & Leverage

Operating CF909.78M USD

CapEx (TTM)480.33M USD

FCF Margin9.07%

FCF Yield1.87%

Net Debt4.09B USD

Net Debt/EBITDA4.01

Balance Sheet

Debt/Equity1.58

Current Ratio1.14

Quick Ratio0.48

Book Value/Sh39.20 EUR

Cash/Share4.22 EUR

Dividends

Fwd Div Rate0.74 EUR

Trail. Div Rate0.74 EUR

Div. Yield0.29%

5Y Avg Yield0.30%

Payout Ratio26.15%

Ex-Div DateMar 27, 2026

Pay Date—

Splits

Last Split4:1

Split DateJun 13, 2016

Analyst Consensus

Rating1.9 (Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)273.63 EUR

Upside (mean)+8.8%

Target Range190.00 EUR – 310.00 EUR

190.00+8.8% to mean310.00

# Analysts19

Ownership

Shares Out.34.81M

Float27.45M

Insiders25.61%

Institutions30.47%

Technical

SMA 50240.55 (+4.6%)

SMA 200233.27 (+7.9%)

Beta1.47

S&P 52W Chg14.58%

Avg Vol (30d)85.60K

Avg Vol (10d)107.56K

Technical Indicators

RSI (14)53.1

MACD4.2736

MACD Signal4.5222

MACD Hist.-0.2486

BB Upper269.79 EUR

BB Middle247.92 EUR

BB Lower226.05 EUR

BB Width17.64%

ATR (14)8.201 EUR

Vol Ratio (20d)0.92x